These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22014965)

  • 1. Defining patient selection for prostate-sparing cystectomy in squamous cell carcinoma of the urinary bladder associated with bilharziasis: an overview of 236 patients.
    Abdelsalam YM; Mokhtar AA; Kurkar AA; Saleh MA; el-Ganainy EO
    Urology; 2011 Dec; 78(6):1351-4. PubMed ID: 22014965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens.
    Richards KA; Parks GE; Badlani GH; Kader AK; Hemal AK; Pettus JA
    Urology; 2010 May; 75(5):1116-20. PubMed ID: 20080289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy.
    Weizer AZ; Shah RB; Lee CT; Gilbert SM; Daignault S; Montie JE; Wood DP
    Urol Oncol; 2007; 25(6):460-4. PubMed ID: 18047952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
    Youssef RF; Shariat SF; Kapur P; Kabbani W; Ghoneim T; King E; Cockburn A; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
    Hum Pathol; 2011 Mar; 42(3):347-55. PubMed ID: 21111452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
    Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
    BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
    Pettus JA; Al-Ahmadie H; Barocas DA; Koppie TM; Herr H; Donat SM; Dalbagni G; Reuter VE; Olgac S; Bochner BH
    Eur Urol; 2008 Feb; 53(2):370-5. PubMed ID: 17689003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review.
    Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA
    BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
    Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
    BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
    Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
    BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radical cystectomy with sparing partial prostate for invasive bladder cancer].
    Zhou FJ; Qin ZK; Han H; Liu ZW; Wu ZG
    Ai Zheng; 2003 Oct; 22(10):1066-9. PubMed ID: 14558952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?
    Sanli O; Acar O; Celtik M; Oktar T; Kilicaraslan I; Ozcan F; Tunc M; Esen T
    Urol Int; 2006; 77(4):307-10. PubMed ID: 17135779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.
    Abdelhady M; Abusamra A; Pautler SE; Chin JL; Izawa JI
    BJU Int; 2007 Feb; 99(2):326-9. PubMed ID: 17026595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?
    Barbisan F; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    BJU Int; 2009 Apr; 103(8):1058-63. PubMed ID: 19076141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.